Skip Navigation

A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy HIPEC with Cisplatin versus no HIPEC at the Time of Interval Cytoreductive Surgery followed by Niraparib Maintenance in Patients with Newly Diagnosed Stage III and IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Hyperthermia Ovarian Treatment Trial

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT05659381

Study #:
STUDY00150913

Start Date:
May 16, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05659381

View Complete Trial Details & Eligibility at ClinicalTrials.gov